Acute pulmonary embolism is a life-threatening condition because it places sudden strain on the right ventricle of the heart.

In patients with unprotected left main stenosis, there was no difference in all-cause mortality at 10 years between patients who had percutaneous coronary intervention and those who underwent coronary ...

Hypereosinophilic syndrome (HES) is a heterogeneous disorder characterised by persistent, abnormal eosinophil elevation in ...

From medical aid to income protection, building a complementary portfolio of cover can make all the difference when illness ...

Siemens Healthineers AG ( OTCPK:SMMNY) Q4 2025 Earnings Call November 5, 2025 2:00 AM EST ...

LAS VEGAS, Nov. 4, 2025 /PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, ...

Background Guidelines strongly recommend reperfusion therapy, including thrombolysis and percutaneous coronary intervention, ...

Q3 2025 Earnings Call November 10, 2025 8:30 AM ESTCompany ParticipantsKate Rausch - Head of Investor RelationsPaul Bolno ...

HF outcomes at 3 years were improved, but where stem cells fit in future research is the big unknown, says Jay Traverse.

Risk stratification of patients with chest pain has traditionally focused on identifying obstructive coronary artery disease (CAD). Using this traditional approach, many symptomatic individuals are ...